| Name | Title | Contact Details |
|---|---|---|
Steven Berkow |
Senior Vice President and General Manager of Workforce Solutions | Profile |
Kirk Manley |
Director, Inbound Marketing, Digital Marketing | Profile |
Aimee Mungovan |
Vice President, Product Management - Patient Experience | Profile |
Jeff Thompson |
Vice President, Client Success | Profile |
Cassandra Willis-Abner |
Chief Human Resources Officer | Profile |
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Interface People is a Lewisville, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Data Health USA is a Ashland, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases.
Chancellor Health Trust is a Palm Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.